Harley E H, Dattolo R A
Department of Otolaryngology-Head and Neck Surgery, Naval Medical Center, San Diego, California, USA.
Otolaryngol Head Neck Surg. 1998 Nov;119(5):492-6. doi: 10.1016/S0194-5998(98)70107-X.
We designed a prospective, randomized, double-blind study to test the efficacy and safety of ibuprofen compared with acetaminophen with codeine for pediatric posttonsillectomy/adenotonsillectomy patients. Twenty-seven children, aged 6 to 16 years, were enrolled. We collected information on pain control, return to normal sleep pattern, return to normal diet, and duration for which medication was required. Coagulation profiles were measured before surgery and on postoperative day 3. Acetaminophen with codeine was more effective in controlling pain on days 1 and 3 (p = 0.0475 and 0.0328, respectively). However, we detected no difference between the treatment groups (p = 0.2216) with regard to pain control on day 5. The ibuprofen group required medication for a longer period (p = 0.0464). We detected no statistically significant differences between groups with regard to return to normal diet (p = 0.2346) and return to normal sleep pattern (p = 0.9554). The postoperative hemorrhage rate was 0% in the acetaminophen-with-codeine group and 12.5% in the ibuprofen group. The ibuprofen group demonstrated a mean increase in bleeding time of 2.07 minutes on the third postoperative day (p = 0.0379). The mean change in postoperative bleeding time between the two groups was statistically significant (p = 0.0140). We found no statistically significant differences in prothrombin time and partial thromboplastin time between groups. On the basis of the findings of this pilot study, we conclude that acetaminophen with codeine is safer and more efficacious than ibuprofen in the management of posttonsillectomy/adenotonsillectomy pain in children.
我们设计了一项前瞻性、随机、双盲研究,以测试布洛芬与对乙酰氨基酚加可待因相比,对小儿扁桃体切除术后/腺样体扁桃体切除术后患者的疗效和安全性。招募了27名6至16岁的儿童。我们收集了有关疼痛控制、恢复正常睡眠模式、恢复正常饮食以及所需用药持续时间的信息。在手术前和术后第3天测量凝血指标。对乙酰氨基酚加可待因在第1天和第3天控制疼痛方面更有效(分别为p = 0.0475和0.0328)。然而,在第5天的疼痛控制方面,我们未发现治疗组之间存在差异(p = 0.2216)。布洛芬组需要用药的时间更长(p = 0.0464)。在恢复正常饮食(p = 0.2346)和恢复正常睡眠模式(p = 0.9554)方面,我们未发现组间有统计学上的显著差异。对乙酰氨基酚加可待因组的术后出血率为0%,布洛芬组为12.5%。布洛芬组在术后第3天的出血时间平均增加了2.07分钟(p = 0.0379)。两组术后出血时间的平均变化具有统计学意义(p = 0.0140)。我们发现组间在凝血酶原时间和部分凝血活酶时间方面没有统计学上的显著差异。基于这项初步研究的结果,我们得出结论,在小儿扁桃体切除术后/腺样体扁桃体切除术后疼痛的管理中,对乙酰氨基酚加可待因比布洛芬更安全、更有效。